{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:28:42Z","timestamp":1788582522571,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,6,13]],"date-time":"2009-06-13T00:00:00Z","timestamp":1244851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s00432-009-0617-1","type":"journal-article","created":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T11:50:25Z","timestamp":1244807425000},"page":"1701-1709","source":"Crossref","is-referenced-by-count":75,"title":["Elimination of high-risk human papillomavirus type HPV16 infection by \u2018Praneem\u2019 polyherbal tablet in women with early cervical intraepithelial lesions"],"prefix":"10.1007","volume":"135","author":[{"given":"Shirish","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok C.","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Showket","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutapa","family":"Mahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Hedau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Kailash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Bhambhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaraj","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. P.","family":"Talwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhudev C.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,13]]},"reference":[{"key":"617_CR1","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.trstmh.2006.01.008","volume":"100","author":"R Bagga","year":"2006","unstructured":"Bagga R, Raghuvanshi P, Gopalan S, Das SK, Baweja R, Suri S, Malhotra D, Khare S, Talwar GP (2006) A polyherbal vaginal pessary with spermicidal and antimicrobial action: evaluation of its safety. Trans R Soc Trop Med Hyg 100:1164\u20131167. doi: 10.1016\/j.trstmh.2006.01.008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"617_CR2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0190-9622(98)70243-9","volume":"38","author":"KR Beutner","year":"1998","unstructured":"Beutner KR, Spruance SL, Hougham AJ, Fox TL, Owens ML, Douglas JM Jr (1998) Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol 38:230\u2013239. doi: 10.1016\/S0190-9622(98)70243-9","journal-title":"J Am Acad Dermatol"},{"issue":"Pt 2","key":"617_CR3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1099\/0022-1317-80-2-409","volume":"80","author":"HJ Bontkes","year":"1999","unstructured":"Bontkes HJ, de Gruijl TD, Walboomers JM, Schiller JT, Dillner J, Helmerhorst TJ, Verheijen RH, Scheper RJ, Meijer CJ (1999) Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16. J Gen Virol 80(Pt 2):409\u2013417","journal-title":"J Gen Virol"},{"key":"617_CR4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/cbic.200300749","volume":"5","author":"G Brahmachari","year":"2004","unstructured":"Brahmachari G (2004) Neem\u2014an omnipotent plant: a retrospection. Chem Bio Chem 5:408\u2013421. doi: 10.1002\/cbic.200300749","journal-title":"Chem Bio Chem"},{"key":"617_CR5","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1371\/journal.ppat.0020069","volume":"2","author":"CB Buck","year":"2006","unstructured":"Buck CB, Thompson CD, Roberts JN, Muller M, Lowy DR, Schiller JT (2006) Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog 2:e69. doi: 10.1371\/journal.ppat.0020069","journal-title":"PLoS Pathog"},{"key":"617_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jmv.1890360402","volume":"36","author":"BC Das","year":"1992","unstructured":"Das BC, Sharma JK, Gopalkrishna V, Das DK, Singh V, Gissmann L, zur Hausen H, Luthra UK (1992) A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol 36:239\u2013245. doi: 10.1002\/jmv.1890360402","journal-title":"J Med Virol"},{"key":"617_CR7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s00262-004-0501-4","volume":"53","author":"S Hallez","year":"2004","unstructured":"Hallez S, Simon P, Maudoux F, Doyen J, Noel JC, Beliard A, Capelle X, Buxant F, Fayt I, Lagrost AC, Hubert P, Gerday C, Burny A, Boniver J, Foidart JM, Delvenne P, Jacobs N (2004) Phase I\/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia. Cancer Immunol Immunother 53:642\u2013650. doi: 10.1007\/s00262-004-0501-4","journal-title":"Cancer Immunol Immunother"},{"key":"617_CR8","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","volume":"364","author":"DM Harper","year":"2004","unstructured":"Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, Dubin G (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364:1757\u20131765. doi: 10.1016\/S0140-6736(04)17398-4","journal-title":"Lancet"},{"key":"617_CR9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","volume":"3","author":"H Hemmi","year":"2002","unstructured":"Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, Tomizawa H, Takeda K, Akira S (2002) Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3:196\u2013200. doi: 10.1038\/ni758","journal-title":"Nat Immunol"},{"key":"617_CR10","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/87.18.1365","volume":"87","author":"GY Ho","year":"1995","unstructured":"Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S (1995) Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87:1365\u20131371. doi: 10.1093\/jnci\/87.18.1365","journal-title":"J Natl Cancer Inst"},{"key":"617_CR11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","volume":"338","author":"GY Ho","year":"1998","unstructured":"Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423\u2013428. doi: 10.1056\/NEJM199802123380703","journal-title":"N Engl J Med"},{"key":"617_CR12","first-page":"547","volume":"123","author":"NS Joglekar","year":"2006","unstructured":"Joglekar NS, Joshi SN, Navlakha SN, Katti UR, Mehendale SM (2006) Acceptability of Praneem polyherbal vaginal tablet among HIV uninfected women and their male partners in Pune, India\u2013Phase I study. Indian J Med Res 123:547\u2013552","journal-title":"Indian J Med Res"},{"key":"617_CR13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.trstmh.2005.01.007","volume":"99","author":"SN Joshi","year":"2005","unstructured":"Joshi SN, Katti U, Godbole S, Bharucha K, KK B, Kulkarni S, Risbud A, Mehendale S (2005) Phase I safety study of Praneem polyherbal vaginal tablet use among HIV-uninfected women in Pune, India. Trans R Soc Trop Med Hyg 99:769\u2013774. doi: 10.1016\/j.trstmh.2005.01.007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"617_CR14","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/sj.bjc.6603375","volume":"95","author":"U Kailash","year":"2006","unstructured":"Kailash U, Soundararajan CC, Lakshmy R, Arora R, Vivekanandhan S, Das BC (2006) Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. Br J Cancer 95:1250\u20131257. doi: 10.1038\/sj.bjc.6603375","journal-title":"Br J Cancer"},{"key":"617_CR15","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","volume":"347","author":"LA Koutsky","year":"2002","unstructured":"Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU (2002) A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347:1645\u20131651. doi: 10.1056\/NEJMoa020586","journal-title":"N Engl J Med"},{"key":"617_CR16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ijc.20668","volume":"113","author":"BK Prusty","year":"2005","unstructured":"Prusty BK, Das BC (2005) Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer 113:951\u2013960. doi: 10.1002\/ijc.20668","journal-title":"Int J Cancer"},{"key":"617_CR17","first-page":"698","volume":"34","author":"A Ray","year":"1996","unstructured":"Ray A, Banerjee BD, Sen P (1996) Modulation of humoral and cell-mediated immune responses by Azadirachta indica (Neem) in mice. Indian J Exp Biol 34:698\u2013701","journal-title":"Indian J Exp Biol"},{"key":"617_CR18","first-page":"485","volume":"12","author":"H Richardson","year":"2003","unstructured":"Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, Coutlee F, Franco EL (2003) The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 12:485\u2013490","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"617_CR19","first-page":"1151","volume":"36","author":"RD Sadekar","year":"1998","unstructured":"Sadekar RD, Kolte AY, Barmase BS, Desai VF (1998) Immunopotentiating effects of Azadirachta indica (Neem) dry leaves powder in broilers, naturally infected with IBD virus. Indian J Exp Biol 36:1151\u20131153","journal-title":"Indian J Exp Biol"},{"key":"617_CR20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0378-8741(96)01487-0","volume":"55","author":"M SaiRam","year":"1997","unstructured":"SaiRam M, Sharma SK, Ilavazhagan G, Kumar D, Selvamurthy W (1997) Immunomodulatory effects of NIM-76, a volatile fraction from Neem oil. J Ethnopharmacol 55:133\u2013139. doi: 10.1016\/S0378-8741(96)01487-0","journal-title":"J Ethnopharmacol"},{"key":"617_CR21","first-page":"363","volume-title":"Medicinal plants of India","author":"GV Satyavati","year":"1976","unstructured":"Satyavati GV, Raina MK, Sharma M (1976) Azadirachta indica. In: Satyavati GV, Raina MK, Sharma M (eds) Medicinal plants of India. Indian Council of Medical Research, New Delhi, p 363"},{"key":"617_CR22","doi-asserted-by":"crossref","DOI":"10.1002\/3527603980","volume-title":"The neem tree: source of unique natural products for integrated pest management, medicine, industry and other purposes","author":"H Schmutterer","year":"1995","unstructured":"Schmutterer H (1995) The neem tree: source of unique natural products for integrated pest management, medicine, industry and other purposes. VCH Weinheim, Hiedelberg"},{"key":"617_CR23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.trstmh.2008.09.012","volume":"103","author":"R Sharma","year":"2009","unstructured":"Sharma R, Mathur A, Chandhiok N, Datey S, Saxena NC, Gopalan S, Sharma S, Mittal S, Sehgal R, Sumandal BK, Chanda A, Salvi V, Mutalik N, Coyaji KJ, Gibsson A, Hazari K, Kalgutkar S, Talwar GP (2009) Phase II clinical trial with Praneem polyherbal tablet for assessment of its efficacy in sympotmatic women with abnormal vaginal discharge. Trans R Soc Trop Med Hyg 103:167\u2013172","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"617_CR24","first-page":"147","volume":"24","author":"M Sikorski","year":"2003","unstructured":"Sikorski M, Zrubek H (2003) Recombinant human interferon gamma in the treatment of cervical intraepithelial neoplasia (CIN) associated with human papillomavirus (HPV) infection. Eur J Gynaecol Oncol 24:147\u2013150","journal-title":"Eur J Gynaecol Oncol"},{"key":"617_CR25","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/jnci\/94.21.1604","volume":"94","author":"JS Smith","year":"2002","unstructured":"Smith JS, Herrero R, Bosetti C, Munoz N, Bosch FX, Eluf-Neto J, Castellsague X, Meijer CJ, Van den Brule AJ, Franceschi S, Ashley R (2002) Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 94:1604\u20131613","journal-title":"J Natl Cancer Inst"},{"key":"617_CR26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/1568011053174828","volume":"5","author":"R Subapriya","year":"2005","unstructured":"Subapriya R, Nagini S (2005) Medicinal properties of neem leaves: a review. Curr Med Chem Anticancer Agents 5:149\u2013156. doi: 10.2174\/1568011053174828","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"617_CR27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/icb.1997.27","volume":"75","author":"GP Talwar","year":"1997","unstructured":"Talwar GP, Raghuvanshi P, Misra R, Mukherjee S, Shah S (1997) Plant immunomodulators for termination of unwanted pregnancy and for contraception and reproductive health. Immunol Cell Biol 75:190\u2013192. doi: 10.1038\/icb.1997.27","journal-title":"Immunol Cell Biol"},{"key":"617_CR28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.8755-8920.2000.430303.x","volume":"43","author":"GP Talwar","year":"2000","unstructured":"Talwar GP, Raghuvanshi P, Mishra R, Banerjee U, Rattan A, Whaley KJ, Zeitlin L, Achilles SL, Barre-Sinoussi F, David A, Doncel GF (2000) Polyherbal formulations with wide spectrum antimicrobial activity against reproductive tract infections and sexually transmitted pathogens. Am J Reprod Immunol 43:144\u2013151. doi: 10.1111\/j.8755-8920.2000.430303.x","journal-title":"Am J Reprod Immunol"},{"key":"617_CR29","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0192-0561(92)90054-O","volume":"14","author":"SN Upadhyay","year":"1992","unstructured":"Upadhyay SN, Dhawan S, Garg S, Talwar GP (1992) Immunomodulatory effects of neem (Azadirachta indica) oil. Int J Immunopharmacol 14:1187\u20131193. doi: 10.1016\/0192-0561(92)90054-O","journal-title":"Int J Immunopharmacol"},{"key":"617_CR30","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199911253412201","volume":"341","author":"KL Wallin","year":"1999","unstructured":"Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J (1999) Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341:1633\u20131638. doi: 10.1056\/NEJM199911253412201","journal-title":"N Engl J Med"},{"key":"617_CR31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H zur Hausen","year":"2002","unstructured":"zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342\u2013350. doi: 10.1038\/nrc798","journal-title":"Nat Rev Cancer"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-009-0617-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-009-0617-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-009-0617-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:39:52Z","timestamp":1559083192000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-009-0617-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,13]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["617"],"URL":"https:\/\/doi.org\/10.1007\/s00432-009-0617-1","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,13]]}}}